October 8 - October 9
Day one, Monday 8th October 2018
+ Rob Niven is a leading asthma specialist in Manchester and the UK.
+ Andrew Wardlaw is a leading specialist in eosinophilic lung disease and asthma.
+ Ian Pavord has led the development of phenotype targeting of asthma.
+ Ruth Green is a Professor of Respiratory Medicine and a mental health champion.
+ Hamish McAllister-Williams is a specialist in the management of affective disorders.
+ Sadia Anwar is the lead consultant for cancer management in Nottingham.
+ David Baldwin has a particular interest in lung cancer interventions and management.
+ Rachael Curley is a specialist in cystic fibrosis management.
+ Robin Condliffe is a specialist in a national pulmonary hypertension centre in Sheffield.
Day two, Tuesday 9th October 2018
+ Judith Hurdman is a lead physician for acute pulmonary embolic disease.
+ Rhona Maclean is a haematologist and lead physician for the treatment of acute PE.
+ Lorraine Harper is a renal physician with a specialist interest in vasculitis.
+ Jo Porter specialises in ILD and has an interest in sarcoidosis.
+ Luke Howard is an expert in pulmonary hypertension and in the interpretation of CPET.
+ David Partridge is a microbiologist with expertise in care of the immunocompromised.
+ Omar Pirzada is a lead physician for the care of TB.
+ Ian Sabroe, David Partridge, Rod Lawson and Alison Condliffe are consultants at Sheffield who all use and discuss the use of macrolide antibiotics in respiratory disease.
GlaxoSmithKline have given funding towards the costs of this meeting, but have had no input into the agenda or content.